Exosomes: Potential Player in Endothelial Dysfunction in Cardiovascular Disease
- PMID: 34669097
- PMCID: PMC8527819
- DOI: 10.1007/s12012-021-09700-y
Exosomes: Potential Player in Endothelial Dysfunction in Cardiovascular Disease
Abstract
Exosomes are spherical bilayer membrane vesicles with an average diameter of 40-100 nm. These particles perform a wide range of biological activities due to their contents, including proteins, nucleic acids, lipids, lncRNA, and miRNA. Exosomes are involved in inflammation induction, oxidative stress and apoptosis, which can be effective in endothelial dysfunction. Due to the induction of mentioned processes in the endothelial cells, the intercellular connections are destroyed, cell permeability increases and finally cell efficiency decreases and functional defects occur. Cardiovascular disease (CVDs) are of consequences of endothelial dysfunction. Thus by identifying the exosome signaling pathways, which induce inflammation, oxidative stress, and apoptosis, endothelial dysfunction and subsequently CVDs can be reduced; exosomes can be used for appropriate target therapy.
Keywords: Cardiovascular disease; Endothelial dysfunction; Exosome; Mechanism.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Similar articles
-
Targeting endothelial exosomes for the prevention of cardiovascular disease.Biochim Biophys Acta Mol Basis Dis. 2020 Aug 1;1866(8):165833. doi: 10.1016/j.bbadis.2020.165833. Epub 2020 May 4. Biochim Biophys Acta Mol Basis Dis. 2020. PMID: 32380265 Review.
-
Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA).Mol Cancer. 2015 Jul 16;14:133. doi: 10.1186/s12943-015-0400-7. Mol Cancer. 2015. PMID: 26178901 Free PMC article.
-
The Roles of Exosome-Derived microRNAs in Cardiac Fibrosis.Molecules. 2024 Mar 7;29(6):1199. doi: 10.3390/molecules29061199. Molecules. 2024. PMID: 38542836 Free PMC article. Review.
-
Sleep Deprivation Promotes Endothelial Inflammation and Atherogenesis by Reducing Exosomal miR-182-5p.Arterioscler Thromb Vasc Biol. 2023 Jun;43(6):995-1014. doi: 10.1161/ATVBAHA.123.319026. Epub 2023 Apr 6. Arterioscler Thromb Vasc Biol. 2023. PMID: 37021573
-
Exosomes and the cardiovascular system: role in cardiovascular health and disease.J Physiol. 2023 Nov;601(22):4923-4936. doi: 10.1113/JP282054. Epub 2022 Mar 30. J Physiol. 2023. PMID: 35306667 Free PMC article.
Cited by
-
Molecular Docking and Intracellular Translocation of Extracellular Vesicles for Efficient Drug Delivery.Int J Mol Sci. 2022 Oct 26;23(21):12971. doi: 10.3390/ijms232112971. Int J Mol Sci. 2022. PMID: 36361760 Free PMC article. Review.
-
Mesenchymal Stem Cell-Derived Exosome-Loaded microRNA-129-5p Inhibits TRAF3 Expression to Alleviate Apoptosis and Oxidative Stress in Heart Failure.Cardiovasc Toxicol. 2022 Jul;22(7):631-645. doi: 10.1007/s12012-022-09743-9. Epub 2022 May 12. Cardiovasc Toxicol. 2022. PMID: 35546649
-
Circulating exosome long non-coding RNAs are associated with atrial structural remodeling by increasing systemic inflammation in atrial fibrillation patients.J Transl Int Med. 2024 Mar 21;12(1):106-118. doi: 10.2478/jtim-2023-0129. eCollection 2024 Feb. J Transl Int Med. 2024. PMID: 38525437 Free PMC article.
-
Plasma exosomes from patients with coronary artery disease promote atherosclerosis via impairing vascular endothelial junctions.Sci Rep. 2024 Nov 30;14(1):29813. doi: 10.1038/s41598-024-81352-8. Sci Rep. 2024. PMID: 39616226 Free PMC article.
-
Advances in treatment strategies based on scavenging reactive oxygen species of nanoparticles for atherosclerosis.J Nanobiotechnology. 2023 Aug 17;21(1):271. doi: 10.1186/s12951-023-02058-z. J Nanobiotechnology. 2023. PMID: 37592345 Free PMC article. Review.
References
-
- Jokinen E. Obesity and cardiovascular disease. Minerva Pediatrica. 2014;67(1):25–32. - PubMed
-
- Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. Journal of the American Society of Nephrology: JASN. 1998;9(12 Suppl):S16–23. - PubMed
-
- Farsad BF, Alavi SM, Ghorbanian G, Fahimi F, Ghaemmaghami Z, Mehr AZ, Bakhshandeh H. The therapeutic efficnecy of ranolazine in comparison with conventional therapy in diabetic individuals with ischemic heart disease; a randomized clinical trial. Journal of Renal Injury Prevention. 2019;9(1):e04–e04.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources